Drug-Resistant Epilepsy refers to a condition where patients continue to experience seizures despite being treated with two or more appropriately chosen anti-epileptic drugs (AEDs). This condition affects approximately 30% of epilepsy patients. Various factors, including genetic mutations, structural brain abnormalities, or metabolic issues, can cause it. Treatment options may include surgery, neurostimulation, and ketogenic diets.
Magnetic Resonance-Guided Laser Interstitial Thermal Therapy (MRgLITT) is an advanced minimally invasive surgical technique that uses real-time monitoring with Magnetic Resonance Imaging (MRI) to precisely deliver thermal energy to target areas via a laser fiber, enabling the ablation treatment of intracranial tissues. The LaserRO™ system offers patients a new treatment option with exceptional precision, minimal invasiveness, and flexible ablation strategies.
The Epilcure™ system is designed for patients aged 14 to 70 with drug-resistant epilepsy. It offers an advanced neuromodulation treatment solution. Your physician will create a personalized treatment plan based on your unique brain activity and provide ongoing, precise adjustments as your condition evolves.